PXXLF
Price:
$0.26
Market Cap:
$11.15M
Poxel S.A., a biopharmaceutical firm in the clinical stage, is dedicated to creating innovative treatments for a range of metabolic disorders, including type 2 diabetes and various liver ailments. Its flagship product, Imeglimin, is an oral drug candidate that has successfully completed Phase III clinical trials in Japan. This promising medication is also undergoing Phase III trials in the United States and Europe for the management of type 2 diabetes. Imeglimin works by enhancing pancreatic beta cell function and mitigating insulin resistance, thereby reducing key cardiovascular and metabolic risk factors such as elevated blood lipid levels and excessive body weight. Additionally, Poxel is ...[Read more]
Industry
Biotechnology
IPO Date
2017-01-06
Stock Exchange
OTC
Ticker
PXXLF
According to Poxel S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -0.87. This represents a change of -8.75% compared to the average of -0.95 of the last 4 quarters.
The mean historical PE Ratio of Poxel S.A. over the last ten years is -4.73. The current -0.87 PE Ratio has changed 1.74% with respect to the historical average. Over the past ten years (40 quarters), PXXLF's PE Ratio was at its highest in in the June 2018 quarter at 6.46. The PE Ratio was at its lowest in in the December 2011 quarter at -17.76.
Average
-4.73
Median
-5.71
Minimum
-18.30
Maximum
9.35
Discovering the peaks and valleys of Poxel S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 103.31%
Maximum Annual PE Ratio = 9.35
Minimum Annual Increase = -237.23%
Minimum Annual PE Ratio = -18.30
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.36 | -40.38% |
| 2023 | -0.61 | -30.37% |
| 2022 | -0.87 | -85.31% |
| 2021 | -5.93 | 7.82% |
| 2020 | -5.50 | -55.29% |
| 2019 | -12.29 | -231.52% |
| 2018 | 9.35 | -237.23% |
| 2017 | -6.81 | 13.55% |
| 2016 | -6.00 | -67.22% |
| 2015 | -18.30 | 103.31% |
The current PE Ratio of Poxel S.A. (PXXLF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.61
5-year avg
-2.65
10-year avg
-4.73
Poxel S.A.’s PE Ratio is less than Eiger BioPharmaceuticals, Inc. (-0.17), greater than Ceapro Inc. (-3.74), greater than Noxopharm Limited (-3.88), greater than Rapid Dose Therapeutics Corp. (-2.86), greater than Progressive Care, Inc. (-0.89), less than Titan Medical Inc. (12.92), less than Bionomics Limited (-0.39), greater than Living Cell Technologies Limited (-11.55), less than Sorrento Therapeutics, Inc. (-0.00), less than American Hemp Ventures, Inc. (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.17 | $12.59M | |
| -3.74 | $13.31M | |
| -3.88 | $14.78M | |
| -2.86 | $1.78M | |
| -0.89 | $13.49M | |
| 12.92 | $13.91M | |
| -0.39 | $8.81M | |
| -11.55 | $11.39M | |
| -0.00 | $16.54M | |
| 0 | $16.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poxel S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poxel S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Poxel S.A.'s PE Ratio?
How is the PE Ratio calculated for Poxel S.A. (PXXLF)?
What is the highest PE Ratio for Poxel S.A. (PXXLF)?
What is the 3-year average PE Ratio for Poxel S.A. (PXXLF)?
What is the 5-year average PE Ratio for Poxel S.A. (PXXLF)?
How does the current PE Ratio for Poxel S.A. (PXXLF) compare to its historical average?